Study objectives: Tourette syndrome (TS) is associated with a variety of neuropsychiatric comorbidities. However, the relationship between TS and sleep disorders in children is less investigated. This nationwide population-based case-control study aimed to determine the correlation of TS and sleep disorders in children. Methods: Patients aged less than 18 years with newly diagnosed TS from 2001 to 2007 were collected (n = 1124) using data from Taiwan's National Health Insurance Research Database and were compared with a comparison cohort (n = 3372). The adjusted hazard ratio (aHR) for developing sleep disorders was calculated by multivariate Cox proportional hazards model. Results: TS was more prevalent in boys, with a male to female ratio of 3.16:1. TS group also had significantly higher urbanization level of residence than controls (p < .001). The overall incidence rate of sleep disorders was 7.24‰ in children with TS, compared to 3.53‰ in controls. The TS group was associated with a significantly higher rate of sleep disorders, with a crude HR of 2.05 (95% confidence inerval [CI] = 1.43-2.95, p < .001). Among the comorbidities of TS, anxiety disorder was associated with the highest risk for sleep disorders (crude HR = 3.26, 95% CI = 1.52-7.00, p < .001). The aHR for TS cohort to develop sleep disorders was 1.72 (95% CI = 1.16-2.53, p = .007).
INTRODUCTION
Tourette syndrome (TS) is a childhood-onset neuropsychiatric disorder characterized by chronic, and often waxing and waning tics. The tics in TS are of multiple types, with more than one motor and at least one phonic tic during the course. Although TS is defined as a movement disorder, it co-occurs with other neuropsychiatric conditions, including attention-deficit hyperactivity disorder (ADHD), obsessive-compulsive disorder (OCD), mood disorders, and learning disabilities. [1] [2] [3] [4] [5] Among the neuropsychiatric conditions associated with TS, ADHD and OCD are widely accepted as genuine comorbidities ("the Tourette's syndrome triad"). 3 Sleep disorders were also reported to be not uncommon in patients with TS. [5] [6] [7] [8] [9] In an early study, sleep disturbances occurred in 62% of patients with TS, and polysomnography study revealed sleep apnea, abnormal arousal pattern, and motor and vocal tics during all stages of sleep. 8 Ghosh et al. recently reported that 64% of TS patients have DSM-V coded sleep disorders. 7 Although sleep disorders are also common in general pediatric population, 10, 11 Modafferi et al. reported that children with tic disorders have an even higher frequency of sleep disorders compared to controls. 12 However, comorbid ADHD and/or OCD may increase the likelihood of sleep problems in patients with TS, 5, [13] [14] [15] suggesting that sleep disturbance in TS patients may be attributed to comorbidities rather than TS itself. Other conditions associated with TS, including anxiety and depression, 12, 16 headache, 17, 18 allergic rhinitis, asthma, and atopic dermatitis, 19 are also implicated in sleep problems. 12, 18, [20] [21] [22] [23] [24] Therefore, to examine the relationship between TS and sleep disorders, these potential confounders should be considered. However, previous researches largely focused on TS only, and these comorbidities were less considered. Moreover, previous reports were often limited by small sample size, casting doubt on whether the results could represent TS patients at the community level. Motivated by these gaps in knowledge, we conducted this nationwide, population-based case-control study to further clarify whether TS is associated with altered incidence of sleep disorders in children.
METHODS

Data Sources
Data analyzed in this study were retrospectively retrieved from the claims of the National Health Insurance Research Database (NHIRD) started since 1996 and maintained by the National Health Research Institutes (NHRI). The NHIRD provides all inpatient and ambulatory medical claims for around 99% of the residents in Taiwan.
Statement of Significance
Both Tourette syndrome and sleep disorders are common neurological problems, and clinical observation indicates that they often co-occur in children. This nationwide population-based study provides evidence that Tourette syndrome is a risk factor for sleep disorders in children. The association between Tourette syndrome and sleep disorders remains significant after adjustment for potential confounders, suggesting that the two conditions may have shared neurobiological basis. The result of this study underscores the importance of screening for sleep problems in children with Tourette syndrome. Further research is needed to identify which specific sleep disorders are associated with Tourette syndrome, and to unravel the mechanistic link between Tourette syndrome and sleep disorders in children. SLEEP, Vol. 40, No. 3, 2017 Tourette Syndrome in Children-Lee et al.
The study cohort was created using the Longitudinal Health Insurance Database 2005 (LHID 2005), which is a subset of the NHIRD, consisting of claims data of 1,000,000 individuals randomly sampled from all population. The data can be retrospectively traced from 1996 onwards and followed up to the end of 2010. To protect the privacy of the insurants in the LHID, scrambled identification numbers were used to link the database before it was released for research use. The NHRI reported no statistically significant differences in gender, age, and health care cost distribution between these subjects and whole insured population. In this study, diseases were classified according to the International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM). Because NHIRD used ICD-8 as disease classification before 2000, and we want to follow up each patient with TS for at least 3 years, we only enrolled patients from 2001 to 2007 in the present study. The institutional review board of National Taiwan University Hospital, Taipei, Taiwan had approved the present study.
Study Population
We identified a cohort of patients newly diagnosed with TS (ICD-9-CM code: 307.2) between January 1, 2001, and December 31, 2007. The date of the initial diagnosis was defined as the index date. Patients 18 years or older and those with a history of TS were excluded. For each TS case identified, three insured controls adhering to the same inclusion criteria were randomly selected into the non-TS cohort. The subjects were frequency-matched by age, gender, and index year to reduce confounding effects of age and gender and to reduce measure bias of follow-up. The case and control groups were compared and followed-up for up till 2010 for subsequent sleep disorders (ICD-9-CM code: 3074 Specific disorders of sleep of nonorganic origin, 32 Other sleep disturbances) events. Information on comorbidities, including obesity (ICD-9-CM code 278.00), depression (ICD-9-CM code 296.3x, 311.xx), anxiety (ICD-9-CM code 300.00-300.09), attention-deficit disorder (ICD-9-CM code 314.xx), allergic rhinitis (ICD-9-CM code 477.0x-477.9x), asthma (ICD-9-CM code 493.xx), atopic dermatitis (ICD-9-CM code 691.8x), were collected from the NHIRD. Extraction of the case and control groups from the database is illustrated in Figure 1 . All original claims data of the extracted subjects were analyzed.
For urbanization level, we used the 4-level notation according to the standards established by the Taiwanese NHRI. 25, 26 Level 1 was defined as the most urbanized area and level 4 as the least urbanized. Level 1 was defined as having a population of >1,250,000 people. Levels 2 and 3 were defined as having a population between 500,000 and 1,250,000 people and between 150,000 and 500,000 people, respectively. Level 4 was defined as having a population <150 000 people.
Statistical Analysis
All of the data were linked using the Microsoft SQL Server 2008 (Redmond, Seattle, WA, USA) and analyzed using the Statistical Product and Service Solutions version 19.0 (SPSS Inc., Chicago, IL, USA). Chi-square and independent t-tests were used to compare differences between the TS and comparison groups. The Kaplan-Meier method and log-rank test were used to estimate the incidence rates of sleep disorders, and to calculate hazard ratios (HR) with their 95% confidence interval (CI) for sleep disorders or other comorbid conditions between the two groups. The Cox proportional hazard model with propensity scores was used to determine the adjusted HRs (aHRs), which compare the incidence rates of sleep disorders between the two groups after adjusting for covariates. Results were considered statistically significant if p values were less than .05.
RESULTS
Demographic Data
The demographic characteristics of the study population were presented in Table 1 . A total of 1124 patients aged less than 18 years with newly diagnosed TS from 2001 to 2007 were enrolled. Boys comprised 76% of the study population, with a male to female ratio of 3.16:1, indicating TS is more prevalent in boys. TS group had significantly higher urbanization level of residence than controls (p < .001). Higher proportion of TS patients lived in level 1 (high) urbanization area compared to controls (30.34% vs. 22.78%), while less TS patients lived in level 4 (low) urbanization area (35.32% vs. 42.82%). Regarding the geographic distribution of study subjects, the majority lived in northern Taiwan, followed by southern, central, and eastern Taiwan, without significant difference between TS and control groups.
The Comorbid Conditions of Sleep Disorders and TS
To investigate the contribution of comorbid conditions to sleep disorders, common diseases associated with sleep disorders were included in the analysis. The most common comorbid conditions associated with sleep disorders in TS group were allergic rhinitis (57.83%), followed by asthma (25.62%), ADHD (18.33%), and atopic dermatitis (10.32%). The most common comorbid conditions in control group were allergic rhinitis (31.82%), followed by asthma (12.99%), and atopic dermatitis (5.37%). All comorbidities except for obesity were significantly more prevalent among TS group compared to controls (p < .001; Table 1 ).
Risk of Sleep Disorders
The prevalence rate of sleep disorders was 4.4% in children with TS, compared to 2.2% in controls (p < .001). The overall incidence rate of sleep disorders was 7.24‰ in children with TS, compared to 3.53‰ in controls. The TS group was associated with a significantly higher rate of sleep disorders, with a crude HR of 2.05 (95% CI = 1.43-2.95, p < .001; Table 2 ). The cumulative incidence rates of sleep disorders in TS and non-TS cohorts were shown in Figure 2 . It showed that the cumulative incidence rates of sleep disorders in TS cohort were significantly higher compared with the non-TS cohort during the entire course of study (p < .001). We further analyzed the risk of sleep disorders in terms of gender and comorbidities. There was no gender or age difference for the risk of sleep disorders in both TS and control groups. Among the comorbidities, anxiety disorder was associated with the highest risk for sleep disorders, with a crude HR of 3.26 (95% CI = 1.52-7.00, p = .002), followed by attention-deficit disorders (crude HR = 2.06, 95% CI = 1.20-3.54, p = .009) and allergic rhinitis (crude HR = 1.60, 95% CI = 1.12-2.28, p = .010). Obesity and depression also appeared to increase the risk for sleep disorders (crude HR = 3.79 and 3.39, respectively), though statistical significance was not reached, probably because obesity and depression were not explicitly diagnosed in some patients. After adjustment for the comorbidities, the HR of sleep disorders in TS versus control groups remained elevated (aHR = 1.72, 95% CI = 1.16-2.53, p = .007). This indicated that the increased risk of sleep disorders in children with TS cannot be fully accounted for by its comorbidities. In other words, TS per se is associated with a higher likelihood of developing sleep disorders in children (Table 3) .
To clarify the relationship among TS and different sleep disorders, HR for different sleep disorders were analyzed. We found that there was no difference in prevalence rate and HR of sleep apnea and insomnia in children with/without TS ( Table 4) . Although the prevalence rate of hypersomnia was 2.3 times higher in children with TS compared with controls, HR of hypersomnia was not increased in TS group. The most significant difference of prevalence rate and HR arose from unspecified sleep disorders. The HR of unspecified sleep disorders was significantly increased in children with TS (p < .001).
For further analysis of the time-course change for sleep disorder risk in children with TS, data analysis was done for both cohorts in the follow-up period (Table 5 and Figure 2 ). The events of sleep disorders in the TS cohort decreased from 11.65 per 1,000 person-years in Year 1 to 2.38 in Year 5 and longer. On the other hand, the sleep disorder rate remained constant at around 2 per 1,000 person-years in the comparison children during the follow-up periods. The risk of developing sleep disorders was significantly higher in Year 1 and Years 2-4, with a crude HR of 5.60 (95% CI = 2.24-14.05, p < .001) and 1.84 24 anxiety, and depression. 20, 21, 23 Children with ADHD are also at higher risk of sleep disorders. 28 In the present study, these risk factors for sleep disorders are also more prevalent in children with TS, and may thus contribute to higher rate of sleep disorders in this patient population. However, after adjustment for these comorbid risk factors, the adjusted HR remains elevated. This indicates that TS per se may increase the risk of sleep disorders in children. Further analysis for both cohorts in the follow-up period revealed that most sleep disorders cases in the TS cohort were identified in earlier follow-up period. It is possible that sleep disorders are a comorbidity being found because of the diagnosis and care of TS. Both TS and sleep disorders exhibit some changes in neurochemical systems. TS is characterized by dysfunction of cortico-striato-thalamo-cortical circuits.
1,4 Diminished serotonin (5-HT) levels results in increased phasic dopamine (DA) release, as well as changes in dopamine D2 receptor (D2R) and serotonin receptor 2A (5-HT 2A R) expressions in TS. 29, 30 Both DA and 5-HT systems and their interaction are also involved in modulation of circadian rhythms.
31,32 D2R 33,34 and 5-HT 2A R 35, 36 are implicated in physiological regulation during sleep. An earlier study revealed increased rate of obstructive sleep apnea in TS families, suggestive of comorbid sleep disorders in TS. 37 In addition, treatment with risperidone, a mixed D2R and 5-HT 2A R antagonist, was associated with improvements of both tics and sleep disturbance in some TS patients. 38 ,39 Jankovic et al. reported that among three patients with both TS and sleep apnea, sleep apnea resolved in 2 patients after treatment with tetrabenazine, a DA-depleting agent. 40 Both suggest the close relationship between sleep disorders and TS. 29, 37 Sleep disorders are also prevalent in other conditions characterized by disturbed dopaminergic signaling, such as schizophrenia and Parkinson's disease, indicating the possible relationship between sleep disorders and DA transmission. 41, 42 Alteration in the cross-talk between orexin and histamine systems provides another possible connection of TS and sleep disorders. 43 The role of orexin and its receptors in sleep disorders is well established. [43] [44] [45] Decreased orexinergic signaling leads to reduced histaminergic neurotransmission, 43 which is implicated in TS. 43, 46, 47 Variants of orexin-2 receptor (OX2R) gene, with their protein products less responsive to agonist, were found in patients with TS and excessive daytime sleepiness, respectively. 45 The coexistence of TS and sleep disorders has therapeutic implications. TS is characterized by sympathetic overflow, 48, 49 which could be attenuated by clonidine, a central-acting α2-adrenergic agonist. Some sleep disorders also display sympathetic overactivation, 50, 51 and clonidine treatment may reduce the risk of hypocapnic sleep apnea. 52 Clonidine may also be helpful for sleep problems in children with neurodevelopmental disorders, including comorbid ADHD in TS. 53 Therefore, the reduced central α2-adrenergic signaling and/or increased sympathetic tone in TS may also facilitate the development of sleep disorders. Although risperidone improved both tics and sleep disturbance in patients with TS, 38, 39 risperidone, and aripiprazole were found to be associated with increased risk of obstructive sleep apnea in an adult study. 54 However, this finding was not confirmed by subsequent study. 55 In the present study, there was no difference in prevalence rate and HR of sleep apnea and insomnia in children with/without TS. Although the prevalence rate of sleep apnea and insomnia was reported to be as high as 1-3% and 20-30%, respectively, in Western countries, 56 the prevalence rate was found to be only 0.7-1.8% and 2-3%, respectively, in Taiwan, 57 and 0.2-0.4% and 0.2-0.3% in the present study. Children with mild symptoms of sleep disorders will not seek for medical advice, leading to relative low prevalence of specific sleep disorders in the present study. In addition, no further evaluation of different sleep disorders may lead to low prevalence for specific sleep disorders in the present study, which is one of limitation using Health Insurance Database for analysis.
There are several other limitations in this study. First, case ascertainment cannot be done owing to the nature of datasets and the policy of the database provider, and diagnosis could be erroneous at times. Second, the severity of TS and sleep disorders cannot be obtained, and specific sleep disorders may not be evaluated, precluding more detailed analysis of their relationship. In addition, only more severe cases of TS will seek for medical advice and treatment, excluding very mild cases of TS. Third, although major comorbid conditions were taken into consideration and HR was adjusted accordingly, they were not exhaustive and other confounders may still exist. Fourth, it is difficult to avoid surveillance bias. Children with TS are more likely to be diagnosed by child neurologists or psychiatrists, and the parents may pay more attention to their comorbid conditions, including sleep disorders. However, in the present study, the prevalence of TS, the age and sex ratios, and the urbanization level in children with TS are similar to the previous studies, 25, 26, 58 indicating that the present dataset is reliable. From this nationwide population-based study, the increased risk of sleep disorders in TS cannot be only attributed to its comorbidities, and therefore TS per se is an independent risk factor for sleep disorders in children with TS.
In conclusion, our study confirms TS as an independent risk factor for sleep disorders in children. Together with other comorbidities, the probability of sleep disorders and attendant neurobehavioral deficits in TS patients is substantial.
Comprehensive care of TS patients should include a screening for comorbid sleep disorders. Adjusted for comorbidities whose univariable analysis was significant.
